Structures by: Rood S. L.
Total: 13
C47H40Cl4N4O4
C47H40Cl4N4O4
Chemical Communications (2019)
a=19.763(2)Å b=7.0061(8)Å c=30.454(4)Å
α=90° β=99.447(2)° γ=90°
C24H19Cl2N5O2
C24H19Cl2N5O2
Chemical Communications (2019)
a=29.485(5)Å b=4.6618(7)Å c=34.442(5)Å
α=90° β=94.016(2)° γ=90°
C24H19Cl2N5O2
C24H19Cl2N5O2
Chemical Communications (2019)
a=29.5915(4)Å b=4.67650(10)Å c=34.4083(5)Å
α=90° β=94.1420(10)° γ=90°
C20H17Cl2N2O2
C20H17Cl2N2O2
Chemical Communications (2019)
a=27.525(3)Å b=7.7860(7)Å c=16.8266(16)Å
α=90° β=90° γ=90°
C24H19Cl2N5O2
C24H19Cl2N5O2
Chemical Communications (2019)
a=29.7548(10)Å b=4.76130(10)Å c=34.8524(7)Å
α=90° β=94.220(4)° γ=90°
C38H30Cl4N4O4
C38H30Cl4N4O4
Chemical Communications (2019)
a=8.6025(16)Å b=14.743(3)Å c=15.818(3)Å
α=113.957(3)° β=90.600(3)° γ=105.072(3)°
Co-crystal of mefenamic acid and 1,2-Bis(4-pyridyl)ethylene
C21H20N2O2
CrystEngComm (2018) 20, 41 6377
a=7.8199(14)Å b=8.6152(15)Å c=12.900(2)Å
α=98.216(2)° β=99.515(2)° γ=90.024(2)°
Co-crystal of mefenamic acid and 1,3-Bis(4-pyridyl)propane
C28H29N3O2
CrystEngComm (2018) 20, 41 6377
a=7.503(3)Å b=7.836(3)Å c=20.382(7)Å
α=88.77(9)° β=85.38(5)° γ=79.99(5)°
Co-crystal of naproxen and 1,2-Bis(4-pyridyl)ethane
C40H40N2O6
CrystEngComm (2018) 20, 41 6377
a=38.014(16)Å b=5.787(3)Å c=15.566(7)Å
α=90° β=93.646(6)° γ=90°
Co-crystal of naproxen and 1,3-Bis(4-pyridyl)propane
C41H42N2O6
CrystEngComm (2018) 20, 41 6377
a=35.567(8)Å b=5.7333(15)Å c=33.199(8)Å
α=90° β=91.732(4)° γ=90°
Co-crystal of naproxen and 4,4'-azopyridine
C38H36N4O6
CrystEngComm (2018) 20, 41 6377
a=15.483(7)Å b=5.745(2)Å c=19.668(8)Å
α=90° β=110.025(8)° γ=90°
Co-crystal of mefenamic acid and 4,4'-azopyridine
C20H19N3O2
CrystEngComm (2018) 20, 41 6377
a=7.549(5)Å b=8.736(6)Å c=13.095(8)Å
α=100.617(10)° β=99.729(9)° γ=93.918(9)°
Co-crystal of mefenamic acid and 1,2-Bis(4-pyridyl)ethane
C21H21N2O2
CrystEngComm (2018) 20, 41 6377
a=7.450(7)Å b=7.835(7)Å c=16.895(16)Å
α=94.30(3)° β=93.160(17)° γ=117.89(2)°